May 8, 2008...Decatur, Illinois – Cancer Care Specialists of Central Illinois (CCSCI) is one of only 10 community oncology practices in the country to receive honors from the American Society of Clinical Oncology (ASCO) and The ASCO Cancer Foundation for efforts to improve care of people with cancer through participation in clinical trials. ASCO’s 2008 Clinical Trial Participation Award (CTPA) will be presented to CCSCI on, June 1, 2008 at ASCO’s 44th Annual Meeting in Chicago.
“This award is made possible through our research partnership with the Decatur Memorial Hospital Cancer Care Institute (DMH CCI,” said CCSCI President James L. Wade III, MD, FACP.
“We are truly honored to receive this special award. We are thankful for the overwhelming support of the people in Decatur and other central and south-central Illinois communities who participate in clinical trials and who are personally contributing to the progress being made against cancer through research.
"In 2007, approximately 10 percent of our patients participated in cancer clinical trials which is twice the national percentage.
"Patients and families in Central Illinois truly benefit from this unique collaboration between DMH CCI and CCSCI which has brought many cutting-edge treatments to Decatur that are not available anywhere else in downstate Illinois.
"This award follows our receipt of the prestigious 'Harry Hynes Award' from the National Cancer Institute last September. This award was given for 'outstanding commitment to community clinical research.' The CCSCI and DMH CCI collaboration is the only research program in Illinois to have received both of these awards.”
Of the 1.3 million people who will be diagnosed with cancer this year, only 3 to 5 percent will participate in cancer clinical trials. In 2007, CCSCI enrolled 247 patients onto clinical trials, giving them the opportunity to receive cutting-edge cancer therapies. CCSCI currently has 85 ongoing clinical trials in more than 25 different cancer types, including breast, colorectal, gynecologic, leukemia, lung, lymphoma, and prostate cancers, as well as several cancer control and symptom management trials.
“Virtually every cancer treatment available today is the direct result of clinical research. ASCO is pleased to honor Cancer Care Specialists of Central Illinois for its dedication to developing new ways to slow, halt, cure and prevent cancer,” said ASCO President Nancy Davidson, MD.
Clinical trials are research studies designed to evaluate whether a new treatment or procedure is safe and effective compared to the current standard of care. Thanks in large part to the knowledge gained through clinical trials, today two-thirds of cancer patients survive at least five years after diagnosis, compared with half in the 1970s.
This year’s award winners were selected based on many factors, including patient accrual to clinical trials over a three-year period. Special consideration was given to practices that increased clinical trial participation among underrepresented populations, as well as practices that used innovative techniques to overcome barriers to the enrollment of cancer patients onto clinical trials. CCSCI's award reflects, in part, "our adaptation of wireless touch pad technology to better capture patients' quality of life symptoms," according to Dr. Wade.
In addition to being a national leader in providing patients access to clinical trials, CCSCI offers patients cancer care and treatment from a compassionate, skilled, and dedicated professional staff. The practice has a patient services navigator to help patients access local, regional, and national resources related to financial, nutritional, counseling, disability, transportation, support groups, and other psychosocial support services and assistance programs.
The Clinical Trials Participation Awards program is supported by a grant from the Coalition of Cancer Cooperative Groups, which enables ASCO to provide award recipients with a travel grant to attend ASCO’s Annual Meeting.
In recognition of the ASCO award, a special ceremony will be held at CCSCI on Thursday, May 8, 2008. CCSCI physicians and DMH CCI research staff will receive an ASCO Clinical Trials Award Recipient research recognition pin, which designates researchers among all ASCO members as CTPA recipients.
For more information on participating in a clinical trial or for a complete list of available clinical trials, please call CCSCI at (217) 876-6600 or contact the DMH Cancer Care Institute at (217) 876-6620.
Cancer Care Specialists of Central Illinois, S.C., (CCSCI) is the largest multi-disciplinary oncology practice south of Interstate 74 serving Central and South-Central Illinois. Founded by James L. Wade, MD, FACP, the practice is based on the foundation of knowledge through research and now includes 14 board-certified physicians specializing in medical oncology, hematology, and radiation oncology. CCSCI physicians and staff are compassionate and caring and dedicated to the communities they serve, including Decatur, Effingham, Centralia, Clinton, Fairfield, Flora, Mattoon, Monticello, Olney, Pana, Shelbyville, Taylorville, and Vandalia.
CCSCI is affiliated with several National Cancer Institute research organizations, including M.D. Anderson Cancer Center, University of Chicago, SWOG, ECOG, and NSABP. CCSCI is also a member of the Central Illinois Community Clinical Oncology Program (CICCOP). Through a partnership with the Decatur Memorial Hospital Cancer Care Institute, CCSCI offers many advanced opportunities to participate in research trials for cancer prevention, treatment, and symptom management. For more information about CCSCI, please call (217) 876-6600 or visit www.cancercarespecialists.org.
The American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 25,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit www.asco.org/presscenter. Patient-oriented cancer information is available at www.cancer.net.
The ASCO Cancer Foundation is the philanthropic arm of the American Society of Clinical Oncology. The ASCO Cancer Foundation is dedicated to improving the lives of people with cancer through programs that support cutting-edge research and education in oncology. The ASCO Cancer Foundation is the torch bearer for the next generation of oncology researchers and the purveyor of knowledge to cancer patients. With the support of the cancer community and the public at large, The ASCO Cancer Foundation is making a world of difference in cancer care.
For more information contact Tricia Henning at (217) 876-6600 or email email@example.com